Artículos por temáticas

Evolution of brain gray matter loss in Huntington's disease: a meta-analysis.

Lambrecq V, Langbour N, Guehl D, Bioulac B, Burbaud P, Rotge JY.

Eur J Neurol. 2013 Feb;20(2):315-21. doi: 10.1111/j.1468-1331.2012.03854.x.

Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease.

Faure A, Es-Seddiqi M, Brown BL, Nguyen HP, Riess O, von Hörsten S, Le Blanc P, Desvignes N, Bozon B, El Massioui N, Doyère V.

Front Behav Neurosci. 2013 Sep 26;7:130. doi: 10.3389/fnbeh.2013.00130.

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.

HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network..

JAMA Neurol. 2013 Jan;70(1):25-33. doi: 10.1001/2013.jamaneurol.382.

Demonstration of choreic movements in a case of chorea gravidarum.

Pathania M, Lali BS, Yadav NK, Chaturvedi A.

BMJ Case Rep. 2013 Feb 15;2013. pii: bcr2012008234. doi: 10.1136/bcr-2012-008234. No abstract available.

CNR1 variation is associated with the age at onset in Huntington disease.

Kloster E, Saft C, Epplen JT, Arning L.

Eur J Med Genet. 2013 Aug;56(8):416-9. doi: 10.1016/j.ejmg.2013.05.007.

The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician.

Martino D, Stamelou M, Bhatia KP.

J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):650-6. doi: 10.1136/jnnp-2012-302532.

Unified Huntington's disease rating scale for advanced patients: validation and follow-up study.

Youssov K, Dolbeau G, Maison P, Boissé MF, Cleret de Langavant L, Roos RA, Bachoud-Lévi AC.

Mov Disord. 2013 Oct;28(12):1717-23. doi: 10.1002/mds.25654.

Why psychometrics is important - a response to: Aubeeluck, Buchanan & Stupple (2013) Journal of Huntington's Disease 2(4) 453-454.

Hagell P, Smith S.

J Huntingtons Dis. 2013;2(4):455-7. doi: 10.3233/JHD-139009. No abstract available.

Autoimmune chorea in adults.

O'Toole O, Lennon VA, Ahlskog JE, Matsumoto JY, Pittock SJ, Bower J, Fealey R, Lachance DH, McKeon A.

Neurology. 2013 Mar 19;80(12):1133-44. doi: 10.1212/WNL.0b013e3182886991.

Enhanced Ca(2+)-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model.

Lee W, Reyes RC, Gottipati MK, Lewis K, Lesort M, Parpura V, Gray M.

Neurobiol Dis. 2013 Oct;58:192-9. doi: 10.1016/j.nbd.2013.06.002.

Euthanasia and physician-assisted suicide in Huntington's disease in The Netherlands.

Booij SJ, Engberts DP, Tibben A, Roos RA.

Int Psychogeriatr. 2013 Feb;25(2):339-40. doi: 10.1017/S1041610212001639. No abstract available.

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.

Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H, Langbehn DR, Jones R, Leavitt BR, Roos RA, Durr A, Johnson H, Lehéricy S, Craufurd D, Kennard C, Hicks SL, Stout JC, Reilmann R, Tabrizi SJ

Hum Brain Mapp. 2013 Mar;34(3):519-29. doi: 10.1002/hbm.21449.

Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease.

Sbodio JI, Paul BD, Machamer CE, Snyder SH.

Cell Rep. 2013 Sep 12;4(5):890-7. doi: 10.1016/j.celrep.2013.08.001.

Further molecular characterisation of the OVT73 transgenic sheep model of Huntington's disease identifies cortical aggregates.

Huntington's Disease Sheep Collaborative Research Group., Reid SJ, Patassini S, Handley RR, Rudiger SR, McLaughlan CJ, Osmand A, Jacobsen JC, Morton AJ, Weiss A, Waldvogel HJ, MacDonald ME, Gusella JF

J Huntingtons Dis. 2013;2(3):279-95. doi: 10.3233/JHD-130067.

The personal experience of parenting a child with juvenile Huntington's disease: perceptions across Europe.

Eatough V, Santini H, Eiser C, Goller ML, Krysa W, de Nicola ', Paduanello M, Petrollini M, Rakowicz M, Squitieri F, Tibben A, Weille KL, Landwehrmeyer B, Quarrell O, Smith JA.

Eur J Hum Genet. 2013 Oct;21(10):1042-8. doi: 10.1038/ejhg.2013.15.